Lumos Pharma, Inc. (LUMO)

Verve Therapeutics Revenue

Lumos Pharma had revenue of $726.00K in the quarter ending September 30, 2024, with 10,271.43% growth. This brings the company's revenue in the last twelve months to $2.21M, up 26.94% year-over-year. In the year 2023, Lumos Pharma had annual revenue of $2.05M with 34.67% growth.

• Revenue (ttm): $2.21M
• Revenue Growth: +26.94%
• P/S Ratio: 16.06
• Revenue / Employee: $66,818
• Employees: 33
• Market Cap: 37.54M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	2.05M	528.00K	34.67%
Dec 31, 2022	1.52M	1.29M	562.17%
Dec 31, 2021	230.00K	62.00K	36.90%
Dec 31, 2020	168.00K	-	-
Dec 31, 2019	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.